phone-icon(+035) 527-1710-70
email-icongoogle@gmail.com
map-iconChoose an address
Eastgate Biotech Eastgate Biotech
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
Menu
Eastgate Biotech Eastgate Biotech
  • NEWSLETTER
  • CONTACT US
  • FAQs
  • SPECIAL OFFER
  • PURCHASE THEME

Press Releases

09 Mar
Uncategorized

EASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY, UT and TORONTO, ON--(Marketwired – September 24, 2015) - EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pha...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH CORP. NAMES NEW PRESIDENT

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO, January 20, 2015 (PRNewswire/-) Eastgate Biotech Corp., formerly EastGate Acquisitions Corporation (OTC...

Continue reading

09 Mar
Uncategorized

GLUCORA, SUPPORT HEALTHY GLUCOSE METABOLISM, NPN

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO, January 23, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical compan...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH PROVIDES UPDATE ON ITS PATENT PORTFOLIO

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate Biotech Patent Portfolio Update: SALT LAKE CITY and TORONTO, February 3, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB:...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH ENGAGES DISTRIBUTION COMPANY FOR ITS NUTRACEUTICAL PRODUCTS FOR CANADIAN MARKET

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO,  February 23, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: EBTI), an emerging pharmaceutical comp...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH RECEIVES PURCHASE ORDER FROM ITS CANADIAN DISTRIBUTOR FOR NUTRACEUTICAL PRODUCTS

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO, March 11, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company ...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH ANNOUNCES THAT PHARMACENTER LTD. WILL COMMENCE MARKETING THE COMPANY’S NUTRACEUTICAL PRODUCTS

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO,  May 26, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company a...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY, FOR ITS NATURAL ANTIBACTERIAL PRODUCTS

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY and TORONTO,  May 28, 2015 (Marketwire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company a...

Continue reading

09 Mar
Uncategorized

UNIVERSITY OF GUELPH AND EASTGATE BIOTECH

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EASTGATE BIOTECH ANNOUNCES THAT ITS RESEARCH COLLABORATOR, THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY R...

Continue reading

09 Dec
Uncategorized

NEW STOCK SYMBOL ETBI

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EASTGATE ACQUISITIONS ANNOUNCES NAME CHANGE TO EASTGATE BIOTECH CORP. AND NEW STOCK SYMBOL SALT LAKE CITY and TORONTO, December 15, ...

Continue reading

  • «
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
  • »

EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.

2203-65 Harbour Square Toronto, Ontario M5J 2L4 Canada
Phone: +1 647 692 0652
WhatsApp: +1 647 692 0652
Our Office
  • New York
  • London SF
  • Cockfosters BP
  • Los Angeles
  • Chicago
  • Las Vegas
Innovative Alternatives to Conventional Pharmaceuticals.
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
  • Compare